Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, China.
Mol Med. 2024 Oct 21;30(1):182. doi: 10.1186/s10020-024-00958-w.
Radiation-induced skin injury (RISI) represents a significant complication in patients receiving radiotherapy and individuals exposed to nuclear accidents, characterized by a protracted wound-healing process relative to injuries from other etiologies. Current preventive and management approaches remain inadequate. Consequently, investigating efficacious intervention strategies that target the disease's progression characteristics holds significant practical importance.
Small interfering RNA (siRNA) and overexpression plasmid were used to modulate the expression of Marvel domain containing 3 (Marveld3) and paired related homeobox 2 (PRRX2). Protein and mRNA levels were estimated by Western Blot and real-time PCR, respectively. Intracellular levels of Malondialdehyde (MDA), a terminal product of lipid peroxidation, were measured following the manufacturer's protocol for MDA assay kit. Similarly, intracellular levels of ferrous iron (Fe) and reactive oxygen species (ROS) were determined using their respective assay kits. Lipid peroxidation status within the cells was evaluated via BODIPY staining. Immunohistochemistry was conducted to ascertain the expression of PRRX2 in skin tissues collected at various time points following irradiation of rats. The H-score method was used to evaluate the percentage of positively stained cells and staining intensity. RNA sequencing, Gene Ontology (GO) analysis, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were conducted by OE Biotech Company.
In this study, our findings indicated that Marveld3 suppression could effectively inhibit lipid peroxidation levels in irradiated skin cells, concomitantly reducing intracellular Fe content. Additionally, the silencing of Marveld3 effectively abrogated the impact of a ferroptosis agonist on cellular viability, resulting in the upregulation of 66 and 178 genes, as well as the downregulation of 188 and 31 genes in irradiated HaCaT and WS1 cells, respectively. Among the differentially expressed genes, the PRRX2 which was found to be involved in the process of ferroptosis, exhibited statistically significant upregulation. And the upregulation of PRRX2 expression may attenuate radiation-induced lipid peroxidation in skin cells, thereby functioning as a potential stress-responsive mechanism to counteract radiation effects.
This study elucidates the role of Marveld3 in radiation-induced ferroptosis in skin cells. Inhibition of Marveld3 led to the upregulation of PRRX2, which subsequently resulted in a reduction of Fe and ROS levels, as well as the suppression of lipid peroxidation. These effects collectively mitigated the occurrence of ferroptosis.
辐射诱导的皮肤损伤(RISI)是接受放射治疗的患者和暴露于核事故的个体的一种严重并发症,其特点是与其他病因引起的损伤相比,伤口愈合过程漫长。目前的预防和管理方法仍然不足。因此,研究针对疾病进展特征的有效干预策略具有重要的实际意义。
使用小干扰 RNA(siRNA)和过表达质粒来调节 Marvel 结构域包含 3(Marveld3)和配对相关同源框 2(PRRX2)的表达。通过 Western Blot 和实时 PCR 分别估计蛋白质和 mRNA 水平。根据 MDA 测定试剂盒的制造商方案测量丙二醛(MDA),一种脂质过氧化的终产物,细胞内水平。同样,使用各自的测定试剂盒测定细胞内亚铁(Fe)和活性氧(ROS)的水平。通过 BODIPY 染色评估细胞内的脂质过氧化状态。进行免疫组织化学染色以确定大鼠照射后不同时间点皮肤组织中 PRRX2 的表达。使用 H 评分法评估阳性染色细胞的百分比和染色强度。通过 OE 生物技术公司进行 RNA 测序、基因本体论(GO)分析和京都基因与基因组百科全书(KEGG)途径富集分析。
在这项研究中,我们的发现表明 Marveld3 抑制可有效抑制辐照皮肤细胞中的脂质过氧化水平,同时降低细胞内 Fe 含量。此外,Marveld3 的沉默有效地消除了铁死亡激动剂对细胞活力的影响,导致辐照 HaCaT 和 WS1 细胞中分别上调 66 和 178 个基因,下调 188 和 31 个基因。在差异表达基因中,发现 PRRX2 参与铁死亡过程,其表达呈统计学显著上调。PRRX2 表达的上调可能减轻皮肤细胞中的辐射诱导的脂质过氧化,从而作为一种潜在的应激反应机制来抵消辐射效应。
本研究阐明了 Marveld3 在皮肤细胞辐射诱导的铁死亡中的作用。Marveld3 的抑制导致 PRRX2 的上调,进而导致 Fe 和 ROS 水平降低,以及脂质过氧化的抑制。这些作用共同减轻了铁死亡的发生。